What we do
We offer tailored support to industry during product development.
Our expertise can help you build the evidence needed to achieve market access. We can advise you about evaluation programmes and facilitate conversations with stakeholders. Our aim is to improve patient access to the best health and care innovations.
How we can help you
Wherever you are in your plans, learn how we can support you to:
- understand the healthcare system
- demonstrate the value of your health technology
- get new and innovative technologies adopted as quickly as possible.
Engage with us
Identify and address gaps in evidence
Use our Medtech Early Technical Assessment (META) Tool to review any gaps in your product development and evidence generation plans.
Get advice about evidence generation
Our scientific advice service can help you develop evidence generation plans that capture what matters to patients and the healthcare system.
Understand market access challenges
Our Office for Market Access (OMA) helps companies to engage with NICE and the healthcare system during product development.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
As health technologies advance, so too must our methods and processes for selecting and evaluating them. Our new manuals explain our approach.
Digital health technologies
We evaluate digital health technologies that offer the greatest potential to improve or transform health and wellbeing.
Our guidance programmes
Find out about our guidance-producing programmes, to help you understand which one would be most appropriate for your technology.
Get a technology evaluated
Innovative access pathways
The Innovative Licensing and Access Pathway (ILAP) aims to accelerate the time to market and facilitate patient access to medicines.
NICE is working with partners to develop an equivalent pathway for medical technologies.
Register a non-pharmaceutical product
HealthTech Connect is a database of devices, diagnostics and digital health technologies intended for use in the UK health and care system.
It is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Register a pharmaceutical product
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
It is used by horizon scanning organisations to help plan and prepare the NHS for the introduction of new medicines, and to support faster adoption.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals (TA)
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies (HST)
Guidance on the use of highly specialised medicines and treatments.
Case studies
Read about recent projects and partnerships.
- Zio XT - From NICE digital health pilot to AI Award winner (March 2022).
- Reveal LINQ - a digital health developer’s journey through NICE (March 2022).
- HeartFlow’s journey from NICE guidance to MedTech Funding Mandate (February 2022).
- New collaboration between NICE and The Academic Health Science Network will help embed innovations into the healthcare system for the benefit of patients (August 2021).
- NICE approves first treatment in pilot of new approach to cost-comparison fast track appraisals (August 2021).
- NICE is gearing up for the evaluation of further digital health technologies as pilot project produces first result (January 2021).
Latest news
Subscribe to NICE news for life sciences - keeping those working within the life sciences sector up-to-date with important developments.
Find out what we've been doing.
- Putting user-needs at the heart of a multi-agency advisory service for artificial intelligence and data-driven technologies (February 2022)
- How is NICE supporting digital health technology developers? (February 2022)
- Working in partnership to harness the potential of digital technology (February 2022)
- NICE publishes new combined methods and processes manual and topic selection manual for its health technology evaluation programmes (January 2022)
- NICE signals commitment to greater flexibility in its evaluation of promising new health technologies and making patient access fairer (January 2022)